Transactions
Affichage de - 693 éléments sur 968
-
US$12m
Contravir
Sole Bookrunner (Follow-on)
-
US$80m
Cara Therapeutics
Co-Manager (Follow-on)
-
US$114m
Penumbra
Co-Manager (Follow-on)
-
US$42m
Health Insurance Innovations
Joint Bookrunner (Secondary Offering)
-
US$146m
Merit Medical
Co-Manager (Follow-on)
-
N/a
VIIAD
Financial Advisor to Healthcare Technology Company VIIAD on its growth investment
-
US$17m
Galena Biopharma
Sole Bookrunner (Follow-on Offering)
-
US$10m
Aldeyra
Joint Bookrunner (Follow-on)
-
US$125m
Synergy Pharmaceuticals Inc.
Joint Bookrunner (Follow-on)
